
|Videos|December 9, 2021
Dr. Venkat emphasizes individualized care for upper tract urothelial carcinoma cases
Author(s)Urology Times staff
“We’re not doing enough lymph node dissections in upper tract disease,” says Siv Venkat, MD, FRCSC.
Advertisement
In this video, Siv Venkat, MD, FRCSC, discusses the takeaways and further research associated with the study, “Comparison of radical nephroureterectomy and segmental ureterectomy in upper tract urothelial carcinoma,” presented recently at the 2021 Society of Urologic Oncology Annual Meeting. Venkat is a urologic oncology fellow at Weill Cornell Medicine and New York-Presbyterian Hospital in New York City, New York.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
High PHI scores are linked to increased odds of significant prostate cancer
2
Trial to evaluate novel combination in BCG-unresponsive NMIBC
3
Dosing begins in trial of alpha radioligand therapy for mCRPC
4
FDA grants fast track designation to Enolen for localized prostate cancer
5




















